S07807 expands New York’s legal definition of an “epinephrine device” to include not only traditional auto-injectors but also FDA-approved epinephrine nasal spray products and other approved epinephrine delivery devices used for emergency treatment of anaphylaxis. The bill updates the Public Health Law, Education Law, and Insurance Law so that existing rules governing possession, training, administration, liability protections, school use, and insurance coverage apply to these newer delivery forms as well.
The bill preserves and extends the current framework that allows certain eligible entities and individuals — including schools, camps, emergency responders, public assembly venues, and other approved organizations — to purchase, possess, train on, and administer epinephrine devices. It also keeps the existing liability protections for good-faith emergency use and clarifies that use of these devices is considered first aid or emergency treatment rather than the unlawful practice of a profession. In the insurance provisions, it continues the requirement that covered plans provide medically necessary epinephrine devices for life-threatening allergic reactions, with an annual out-of-pocket cap of $100.
In the education context, the bill updates school-related provisions so students with allergies may carry and use prescribed epinephrine devices, schools may keep spare devices on site, and school personnel may be trained to administer them in emergencies. It also aligns the terminology in school health statutes with the broader definition so that nasal spray epinephrine products are treated the same as auto-injectors for purposes of school access, training, and emergency response.
The bill’s overall impact is to modernize state law to reflect newer FDA-approved epinephrine delivery methods and ensure they are covered by the same public health, school, liability, and insurance rules already in place for auto-injectors. Affected parties include schools, camps, first responders, public venues, health care practitioners, pharmacists, insurers, and individuals at risk of anaphylaxis. The measure also preserves the ability of local governments to maintain existing local laws on public assembly venue requirements.
The sentiment around the bill appears strongly favorable and noncontroversial. It passed the Senate 58-0 and the Assembly 143-0, with no recorded opposition in either chamber and no committee transcript indicating debate. The main point of policy discussion embedded in the text is not whether to expand access, but how to integrate the new device type into existing law while preserving training requirements, liability limits, and insurance cost-sharing rules.
This bill amends the Public Health Law, Education Law, and Insurance Law to replace references to “epinephrine auto-injector” with the broader term “epinephrine device” and to define that term to include FDA-approved nasal spray and other epinephrine delivery products. It extends existing authorization, training, liability, school administration, and insurance coverage provisions to these devices, while maintaining current safeguards and cost-sharing limits. It also preserves local authority over certain public assembly requirements where local laws already exist.
The bill appears to have broad bipartisan support and little to no opposition. It passed both the Senate and Assembly unanimously, and there are no committee transcript snippets showing disagreement or controversy. The legislative tone suggests a practical public-health update intended to keep state law aligned with newer FDA-approved epinephrine products.
There is little visible contention in the available record. The only potentially sensitive issues are the scope of entities allowed to possess and administer epinephrine devices, the training requirements for non-medical personnel, and the interaction between state standards and preexisting local laws for public assembly venues. However, the bill text preserves existing liability protections and local-law carveouts, which suggests these issues were addressed in a way designed to minimize conflict.